Literature DB >> 19148506

Long-term results and management of ureteral transitional cell carcinoma using the holmium: YAG laser via rigid-ureteroscopy.

Yoshiaki Yamada1, Yasusuke Inoue, Kogenta Nakamura, Katsuya Naruse, Shigeyuki Aoki, Tomohiro Taki, Motoi Tobiume, Kenji Zennami, Remi Katsuda, Kouji Hara, Yoshiharu Kato, Masahito Watanabe, Keiko Hayashida, Yumi Suzuki, Hitomi Kato, Reiko Ajisaka, Inbou Kyoku, Hiroshi Noguchi, Nobuaki Honda.   

Abstract

The standard operative procedure for ureteral transitional cell carcinoma is nephrouterectomy with partial cystectomy at the affected ureteral orifice. However, nephron-sparing surgery and endoscopic surgery and management have become common practice for low-grade and low-stage cases. We investigated the follow-up results of patients who underwent endoscopic surgery using the holmium:YAG laser, and evaluated its treatment effect. The patients were 4 men and 3 women aged from 68 to 87 years (mean: 74.7 years). Two were imperative cases and 5 were elective cases. The tumor size ranged from 8 to 25 mm (mean: 15.4 mm). Hydronephrosis was not found in any case, and urinary cytology was negative in all cases. Biopsy revealed 5 cases of grade 1, and 2 of grade 2. A Versa Pulse Select 80 laser generator, a 365-microm slim line laser fiber, and a rigid ureteroscope with 8F-point diameter were used. A 6F double J catheter was placed postoperatively for 3 weeks. Pulse energy was set at 0.5-1.0 J (mean: 0.8 J) with a frequency of 10 Hz. The total amount of energy was 0.9-11.22 KJ (mean: 2.89 KJ) and the operation time including ureteral stent placement was 20-97 min (mean: 66 min). Neither urinary tract perforation nor ureteral stricture associated with laser irradiation was observed. The postoperative follow-up period ranged from 23-88 months (mean: 67.8 months). Patients underwent urinary cytological examination once a month, and cystoscopy, retrograde pyelography and urethroscopy once every 3 months for 2 years, then once every 6 months thereafter. One patient developed tumor recurrence 23 months after surgery and received another laser treatment, but no recurrence has been observed in the other 6 patients (85.7%). Transurethral endoscopic surgery and management using the holmium:YAG laser is safe and effective nephron-sparing surgery for ureteral transitional cell carcinoma, and good long-term treatment results can be expected even in elective cases if the indications are carefully selected.

Entities:  

Mesh:

Year:  2009        PMID: 19148506

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Urethroscopic holmium: YAG laser ablation for acquired posterior urethral diverticulum after repair of anorectal malformations.

Authors:  Shinya Takazawa; Hiroo Uchida; Hiroshi Kawashima; Yujiro Tanaka; Takayuki Masuko; Kyoichi Deie; Hizuru Amano; Kenichiro Kobayashi; Minoru Tada; Tadashi Iwanaka
Journal:  Pediatr Surg Int       Date:  2014-07-26       Impact factor: 1.827

2.  Holmium:YAG laser ablation of upper urinary tract transitional cell carcinoma with new Olympus digital flexible ureteroscope.

Authors:  Pablo Garrido Abad; Almudena Coloma Del Peso; Manuel Fernández Arjona
Journal:  Urol Ann       Date:  2013-07

3.  Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study.

Authors:  Jin Wen; Zhi G Ji; Han Z Li
Journal:  BMC Cancer       Date:  2018-02-17       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.